Table 4.

Sensitivity analysis for missing postoperative data

	Short term (6 months)*	Long term (2 years)*	Range
Symptoms
Premenstrual pain	9	8	(0–10)
Menstrual pain	10	10	(0–10)
Non-cyclical pelvic pain	7	6	(0–10)
Deep dyspareunia	8	6	(0–10)
Cyclical dyschezia	7	7	(0–10)
Non-cyclical dyschezia	5	3	(0–10)
Low back pain	7	7	(0–10)
Bladder pain	2	1	(0–10)
Voiding difficulty	0	NS	(0–10)
Frequent bowel movements†	3	3	(0–4)
Urgent bowel movements†	2	2	(0–4)
Incomplete bowel movements†	2	2	(0–4)
Constipation†	2	2	(0–4)
Blood in the stool†	0	1	(0–4)
Quality of life†
EQ visual analogue score	40	55	(0–100)
EQ5D usual activities	2	1	(0–2)
EQ5D pain and discomfort	2	2	(0–2)
EQ5D anxiety and depression	1	1	(0–2)
EQ5D mobility	1	1	(0–2)
EQ5D self-care	1	1	(0–2)
EQ5D index	0.45	0.65	(−0.594 to 1)

*The worst possible score that could be reported for all the missing postoperative data in order for the short-term (6 months) or long-term statistics in tables 3 and 4 to still be significant. (The test statistics that were not significant (NS) to start with have not been included.)

†A high EQVAS or EQ5D index score is associated with an improvement in QoL, whereas with all other QoL and symptom scores, a low value is associated with improvement.

EQ5D, EuroQol 5D; EQVAS, EuroQol Visual Analogue Scale; QoL, quality of life.